The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
about
Agents for inhibiting the adhesion of red blood cells to the endothelium in people with sickle cell diseaseTreatment for avascular necrosis of bone in people with sickle cell diseaseTreatment for avascular necrosis of bone in people with sickle cell diseaseAntibiotics for treating community acquired pneumonia in people with sickle cell diseaseAntibiotics for treating osteomyelitis in people with sickle cell diseaseTreatment for avascular necrosis of bone in people with sickle cell diseaseInterventions for treating painful sickle cell crisis during pregnancyAntibiotics for treating osteomyelitis in people with sickle cell diseaseAntibiotics for treating osteomyelitis in people with sickle cell diseaseInterventions for treating painful sickle cell crisis during pregnancyAntibiotics for treating community acquired pneumonia in people with sickle cell diseaseTreatment for avascular necrosis of bone in people with sickle cell diseaseThe role of adenosine signaling in sickle cell therapeuticsMEK inhibitors, novel anti-adhesive molecules, reduce sickle red blood cell adhesion in vitro and in vivo, and vasoocclusion in vivoRoles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseasesAdvances in sickle cell therapies in the hydroxyurea eraSickle Cells Abolish Melanoma Tumorigenesis in Hemoglobin SS Knockin Mice and Augment the Tumoricidal Effect of Oncolytic Virus In VivoEndothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease.Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease.Magnetic resonance imaging in pediatric sickle cell anemia.Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia.Blood coagulation, inflammation, and malaria.Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell diseaseImaging in childhood arterial ischaemic stroke.Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe.Microvascular oxygen consumption during sickle cell pain crisis.Antisickling property of fetal hemoglobin enhances nitric oxide bioavailability and ameliorates organ oxidative stress in transgenic-knockout sickle mice.Placenta growth factor in sickle cell disease: association with hemolysis and inflammation.Delayed hemolytic transfusion reaction in sickle cell diseaseThe HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice.Nuclear factor-kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease.Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.Frequent red cell transfusions reduced vascular endothelial activation and thrombogenicity in children with sickle cell anemia and high stroke riskIntercellular adhesion molecule-4 and CD36 are implicated in the abnormal adhesiveness of sickle cell SAD mouse erythrocytes to endothelium.Iron overload in sickle cell disease.Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexesGenetic modifiers of the severity of sickle cell anemia identified through a genome-wide association studyArginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients.Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.
P2860
Q24188211-C55442A2-5935-464C-81D0-977B76C6FB96Q24194880-C8456429-A27C-4322-8DE5-D9837354598EQ24197657-AB7DD6FF-F987-4A89-9001-9437B063B1ABQ24197977-CF9F0D09-9355-43F9-8DED-73D059845798Q24202271-A00C2D1D-55E7-4802-99E2-EDD0F20B5EFEQ24239919-F21D9AC5-7858-4235-86F5-F8A616DA4673Q24241423-11EF0A1F-6EAD-4B57-8B9B-8BA59423BE0FQ24241588-6CFF4E88-1D28-4CCA-8267-EEBA6F768394Q24243577-3F92BBCE-9AF1-4464-8CEB-44E57E6DA132Q24243706-9D5CEC48-C9C7-4FCF-B9D3-7C6AEEB1F29AQ24245077-53FFF172-0C86-4A67-9D77-141277835E19Q26470484-4FC6A0F8-28E6-4B35-B8A2-6C1E4C027C9BQ27010098-51D989D0-504F-4E8C-8E6A-12B18C5C8376Q27335195-7D26A680-50F4-404F-BD68-D17415A4E2E8Q28079028-B0FC55F3-3A0E-4DC8-AB2B-64A35E524978Q28088552-539E30A1-23DF-47F4-BB43-2CE183EE7090Q28596621-18C51B8B-8A47-4604-B131-AD3207A8967FQ30481575-6354509C-AF93-4F9A-BF52-D0A4D4C37E69Q30498050-CC6F04DC-EB92-485E-90BE-7D112152ECAAQ30945205-A2D86DF1-DD01-4AB8-AC24-697C402CAE2FQ31116644-B177B300-45F2-4411-B78F-C9A39CF534E5Q33365378-C0AEC11F-7EDC-4EB0-874A-F404954E24E1Q33378580-1F053B12-D66D-417F-8B4B-20D6350443DDQ33385956-B88959B8-54E4-4421-9C6A-4B9DC6041594Q33571760-C228D18D-A34C-4E60-8627-4A2C2A04E29DQ33574142-7CFBE627-D734-4BA5-8309-7118728235BAQ33621596-50C3D104-F67F-4AA8-A0C7-6402CB8C9F15Q33686611-16809DB7-F21F-4175-A07D-713B4775D484Q33722654-FF203237-5EE6-45BB-A0D4-6C287E1F9D8EQ33724538-E6DEDFA0-D972-4FBB-81F2-8B225AD258F2Q33754648-07253A35-7693-4DED-952E-09BC8C7B2B2EQ33761124-FCF2B1A6-DC5A-4AC8-8594-035862F59CBFQ33803027-710B9DB3-EB59-4B0F-AD53-8C6CBB208482Q33804615-D0885872-8403-4A03-A46F-2FF9C1561E9EQ33829064-30D2159D-8A57-4471-AC67-CAFBA755CC1BQ33861129-4AAE6FF6-848B-4062-8D1F-8A626370801FQ33941766-461D2593-3097-4A28-AF97-0CF2D7FD3A81Q33989325-D08AD3FF-B633-4B49-B258-6675373A2A87Q34013495-EDE2A85C-1C80-439F-A177-0C2D1BE1617DQ34033859-E598EC63-E18D-4BD5-81D6-89FB5CCC9777
P2860
The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
@ast
The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
@en
type
label
The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
@ast
The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
@en
prefLabel
The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
@ast
The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
@en
P2093
P356
P1433
P1476
The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
@en
P2093
Dhananjay Kaul
Raymond Osarogiagbon
Robert P Hebbel
P304
P356
10.1080/MIC.11.2.129.151
P577
2004-03-01T00:00:00Z